VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 2021 · 108th Congress

Access to Cancer Clinical Trials Act of 2003

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

DPR PryceSponsor
6 cosponsors · 5 D, 1 R

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Access to Cancer Clinical Trials Act of 2003 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to provide coverage for qualified individuals participating in approved cancer clinical trials if a group health plan or an issuer offering health insurance coverage in connection…

What it does: CRS summary · Introduced in House · May 7, 2003
Access to Cancer Clinical Trials Act of 2003 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to provide coverage for qualified individuals participating in approved cancer clinical trials if a group health plan or an issuer offering health insurance coverage in connection with a group health plan or in the individual market otherwise provides coverage to such an individual.

Directs the Secretaries of Health and Human Services (HHS), of Labor, and of the Treasury to: (1) analyze cancer clinical research and its cost implications for managed care; and (2) report to Congress an assessment of any incremental cost to group health plans resulting from this Act and any recommendations regarding action on other diseases.

Requires the Secretaries of Labor, of the Treasury, and of HHS to ensure coordinated administration of this Act.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Access to Cancer Clinical Trials Act of 2003

Latest action (May 27, 2003): Referred to the Subcommittee on Employer-Employee Relations.

Policy area: Health · Origin: House · Introduced: May 7, 2003

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.